Table 3 Haemodynamic parameters for the patients who developed LCOS in the two study groups
Beta-agonists (n = 50) | Levosimendan (n = 50) | |
|---|---|---|
Mean ± SD | Mean ± SD | |
Heart rate (beats / minute) (at diagnosis of Low Cardiac Output Syndrome) | 78.7 ± 16.2 | 79.8 ± 12.4 |
Heart rate (beats / minute) (at 48 h. of treatment) | 83.9 ± 16.2 | 82.82 ± 20.9 |
Mean blood pressure (mmHg) (at diagnosis of Low Cardiac Output Syndrome) | 68.7 ± 11.11 | 67.5 ± 10.3 |
Mean blood pressure (mmHg) (at 48 h of treatment) | 75.6 ± 9.3 | 70.4 ± 13.2 |
Central venous pressure (mmHg) (at diagnosis of Low Cardiac Output Syndrome) | 9.7 ± 4.6 | 8.7 ± 3.6 |
Central venous pressure (mmHg) (at 48 h of treatment) | 10.1 ± 3. 3 | 10.7 ± 2.2 |
Cardiac index (l/min/m2) (at diagnosis of Low Cardiac Output Syndrome) | 2.4 ± 0.7 | 2.1 ± 0.4 |
Cardiac index (l/min/m2) (at 48 h. of treatment) | 2.6 ± 0.4 | 2.9 ± 17.6 |
SatVO2 (%) (at diagnosis of Low Cardiac Output Syndrome) | 65.3 ± 9.9 | 65.9 ± 10.3 |
SatVO2 (%) (at 48 h of treatment) | 71.71 ± 9. 9 | 64.7 ± 12.5 |